What is the best pharmacologic treatment for sickle cell disease pain crises? (se deschide o fereastră nouă)

Baker M, Hafner JW.

Sursă‎: Ann Emerg Med 2012;59(6):515-6.

Index‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (se deschide o fereastră nouă)

Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate. (se deschide o fereastră nouă)

Frei-Jones MJ, Field JJ, DeBaun MR.

Sursă‎: Pediatr Blood Cancer 2009;53(3):401-5.

Index‎: PubMed 19422031

DOI‎: 10.1002/pbc.22048

https://www.ncbi.nlm.nih.gov/pubmed/19422031 (se deschide o fereastră nouă)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (se deschide o fereastră nouă)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Sursă‎: Thromb Haemost 2007;98(2):392-6.

Index‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (se deschide o fereastră nouă)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (se deschide o fereastră nouă)

Okomo U, Meremikwu MM.

Sursă‎: Cochrane Database Syst Rev 2012;(6):CD005406.

Index‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (se deschide o fereastră nouă)

Guidelines for the management of the acute painful crisis in sickle cell disease. (se deschide o fereastră nouă)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Sursă‎: Br J Haematol 2003;120(5):744-52.

Index‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (se deschide o fereastră nouă)

The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome. (se deschide o fereastră nouă)

Ahmad FA, Macias CG, Allen JY.

Sursă‎: J Pediatr Hematol Oncol 2011;33(6):415-20.

Index‎: PubMed 21792036

DOI‎: 10.1097/MPH.0b013e31821ed4ce

https://www.ncbi.nlm.nih.gov/pubmed/21792036 (se deschide o fereastră nouă)

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (se deschide o fereastră nouă)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Sursă‎: Hemoglobin 2004;28(2):85-102.

Index‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (se deschide o fereastră nouă)

Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. (se deschide o fereastră nouă)

Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR.

Sursă‎: Blood 1998;92(9):3082-9.

Index‎: PubMed 9787142

https://www.ncbi.nlm.nih.gov/pubmed/9787142 (se deschide o fereastră nouă)

A short course of prednisone in the management of acute chest syndrome of sickle cell disease. (se deschide o fereastră nouă)

Kumar R, Qureshi S, Mohanty P, Rao SP, Miller ST.

Sursă‎: J Pediatr Hematol Oncol 2010;32(3):e91-4.

Index‎: PubMed 20216237

DOI‎: 10.1097/MPH.0b013e3181c29c52

https://www.ncbi.nlm.nih.gov/pubmed/20216237 (se deschide o fereastră nouă)

A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. (se deschide o fereastră nouă)

Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP.

Sursă‎: Haematologica 2013;98(9):1375-82.

Index‎: PubMed 23645695

DOI‎: 10.3324/haematol.2013.086637

https://www.ncbi.nlm.nih.gov/pubmed/23645695 (se deschide o fereastră nouă)

Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. (se deschide o fereastră nouă)

Weiner DL, Hibberd PL, Betit P, Cooper AB, Botelho CA, Brugnara C.

Sursă‎: JAMA 2003;289(9):1136-42.

Index‎: PubMed 12622584

https://www.ncbi.nlm.nih.gov/pubmed/12622584 (se deschide o fereastră nouă)

Predictors of bacteremia in febrile children with sickle cell disease. (se deschide o fereastră nouă)

West DC, Andrada E, Azari R, Rangaswami AA, Kuppermann N.

Sursă‎: J Pediatr Hematol Oncol 2002;24(4):279-83.

Index‎: PubMed 11972096

https://www.ncbi.nlm.nih.gov/pubmed/11972096 (se deschide o fereastră nouă)